Key Developments: Varian Medical Systems Inc (VAR.N)

VAR.N on New York Stock Exchange

80.99USD
22 Oct 2014
Price Change (% chg)

$-0.85 (-1.04%)
Prev Close
$81.84
Open
$81.78
Day's High
$82.11
Day's Low
$80.72
Volume
338,217
Avg. Vol
149,491
52-wk High
$87.85
52-wk Low
$72.00

Search Stocks

Latest Key Developments (Source: Significant Developments)

Varian Medical Systems Inc signs agreement to acquire Velocity Software Platform
Wednesday, 12 Mar 2014 08:00am EDT 

Varian Medical Systems Inc:Signs an agreement with Velocity Medical Solutions, LLC to acquire certain assets of Velocity.Acquisition includes software designed to access and aggregate unstructured treatment and imaging data from diverse systems to show a comprehensive view of a patient's diagnostic imaging and treatment history, regardless of where they were treated or what technology was used.Financial terms of the asset acquisition are not being disclosed.Acquisition is expected to close during Varian's third fiscal quarter.  Full Article

Varian Medical Systems Inc elects R. Andrew Eckert as Chairman
Thursday, 20 Feb 2014 07:10pm EST 

Varian Medical Systems Inc:Announced that R. Andrew Eckert elected as Chairman of the Board.Says the appointment effective from Feb. 20, 2014.Says Eckert is succeeding Richard M. Levy, who is retiring.  Full Article

Varian Medical Systems Inc announces imaging components supply agreement with Toshiba Medical Systems
Monday, 27 Jan 2014 08:00am EST 

Varian Medical Systems Inc:Says it has entered into a three-year agreement worth an estimated $515 mln for Varian to supply medical imaging components to Toshiba Medical Systems for integration into imaging equipment for the global market.  Full Article

Varian Medical Systems Inc reaffirms FY 2014 guidance; gives Q2 2014 guidance below analysts' estimates
Wednesday, 22 Jan 2014 04:05pm EST 

Varian Medical Systems Inc:Continues to expect FY 2014 total company revenues could increase by about 6 to 8 percent over FY 2013.Net earnings per diluted share for the FY 2014 could be in the range of $4.22 to $4.34.Expects total company revenues for Q2 2014 to be about equal to Q2 2013 when proton revenues were high.Net earnings per diluted share for Q2 2014 could be in the range of $1.00 to $1.04.The company reported revenue of $2.943 bln in FY 2013.The company reported revenue of $768 mln in Q2 2013.FY 2014 revenues of $3.139 bln and EPS of $4.34 - Thomson Reuters I/B/E/S.Q2 2014 revenues of $808 mln and EPS of $1.10 - Thomson Reuters I/B/E/S.  Full Article

Varian Medical Systems Inc receives FDA 510 clearance for ProBeam proton therapy system
Wednesday, 15 Jan 2014 08:30am EST 

Varian Medical Systems Inc:Says it has received FDA 510 clearance for its updated ProBeam proton therapy system.Says its ProBeam system gives clinicians options for delivering dose precisely in order to minimize dose to healthy tissue in the course of delivering proton therapy treatments for cancer.Says its scanning beam technology enables intensity-modulated proton therapy by modulating dose levels on a spot-by-spot basis throughout the treatment area. Irradiations from multiple angles are combined in an optimal manner to improve control of dose distributions.  Full Article

Varian Medical Systems Inc Issues Q1 2014 Guidance Below Analysts' Estimates; Issues FY 2014 Revenue Guidance In Line With Analysts' Estimates; FY 2014 EPS Guidance Below Analysts' Estimates
Wednesday, 23 Oct 2013 04:02pm EDT 

Varian Medical Systems Inc announced that for the first quarter 2014, it expects revenues to grow by 6-7% and earnings per diluted share (EPS) to be in the range of $0.87 to $0.91. For fiscal 2014, it expects revenues to grow in the range of 6-8% and earnings per diluted share to be in the range of $4.22-$4.34. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $726 million and EPS of $0.96 for first quarter of 2014; revenue of $3.165 billion and EPS of $4.51 for fiscal 2014.  Full Article

Varian Medical Systems Inc Lowers FY 2013 Guidance
Wednesday, 24 Jul 2013 04:06pm EDT 

Varian Medical Systems Inc announced that for fiscal 2013, it expects revenues could increase by about 5% over the fiscal 2012 total and Net earnings per diluted share(EPS) could be in the range of $4.00 to $4.04. The Company reported revenue of revenue of $2.807.00 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $3.029.85 billion and EPS of $4.10 for fiscal 2013.  Full Article

Varian Medical Systems Inc Receives FDA 510(k) Clearance Of Its Nexus DRF Digital X-Ray Imaging System
Wednesday, 22 May 2013 08:00am EDT 

Varian Medical Systems Inc announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Varian's diagnostic X-ray image processing workstation that combines radio frequency (RF) and digital radiography (DR) capabilities on one platform. Varian's Nexus DRF Digital X-Ray Imaging System has the ability to interface with a variety of image receptors, including CCD cameras and commercially available flat-panel image detectors. The Nexus system enables an operator to acquire, display, process, transmit, export, or print high resolution X-ray images. The advanced image processing algorithms make it possible to bring out diagnostic details that can be difficult to see using conventional imaging techniques. The major system components include an image detector, a computer, a high resolution monitor, and Varian's image processing software. Each system can be set up to process data from multiple receptors and detectors.  Full Article

Varian Medical Systems Inc Issues Q3 2013 Guidance; EPS Guidance Below Analysts' Estimates; Reaffirms FY 2013 Guidance
Wednesday, 24 Apr 2013 04:01pm EDT 

Varian Medical Systems Inc announced that for the third quarter of 2013, total Company revenues could increase by about 7% over the prior-year quarter. Net earnings per diluted share for the third quarter should be in the range of $0.98 to $1.02. For fiscal 2013, the Company continue to believe that total company revenues could increase by about 8% over the prior fiscal year and that net earnings per diluted share (EPS ) for fiscal 2013 could be in the range of $4.09 to $4.14. The Company reported revenue of $705.25 million in the third quarter of 2012 and revenue of $2.807 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $767.59 million and EPS of $1.05 for the third quarter of 2013; and revenue of $3.035 billion and EPS of $4.12 for fiscal 2013.  Full Article

Varian Medical Systems Inc Receives FDA 510(k) Clearance For Edge Radiosurgery Suite For Non-Invasive Surgical Procedures
Thursday, 24 Jan 2013 08:01am EST 

Varian Medical Systems Inc announced that it has received FDA 510(k) clearance for the Company's Edge radiosurgery suite, a new dedicated system for performing advanced radiosurgery using real-time tumor tracking and motion management technologies.  Full Article

Philips, IBA strike partnership deal for cancer centers

BRUSSELS - Philips and Belgium's Ion Beam Applications announced a partnership on Thursday designed to combine IBA's cancer-therapy technology with Philips' medical imaging systems.

Search Stocks